KALSIOM SAS

📍 Brest, France🗓 Founded 2020👥 7 employees💰 Last funded Jun 2020
Biotechnology Research🌐 kalsiom.com
Website LinkedIn
KALSIOM is a biotech company founded in April 2020 and based in Brest, France, discovering and developing first-in-class therapies to treat auto-immunes disorders (AID) involving B-cell dysfunction with a high medical need. The company is focusing on developing first-in-class monoclonal antibodies modulating calcium-signaling pathways in lymphocytes.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in KALSIOM SAS?
KALSIOM SAS has 1 investors on record on gritt.io, including 1 early-stage backers.
When did KALSIOM SAS last raise funding?
The most recent investment in KALSIOM SAS recorded on gritt.io was in June 2020.
When was KALSIOM SAS founded?
KALSIOM SAS was founded in 2020.
What industry is KALSIOM SAS in?
KALSIOM SAS operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is KALSIOM SAS based?
KALSIOM SAS is headquartered in Brest, France.